Artidis

Artidis develops nanomechanical measurement technology that uses atomic force microscopy (AFM) to measure the mechanical properties of tumors and their microenvironment. Its ARTIDIS Research Device is an automated, AI-assisted AFM platform, and Artidisnet is a cloud platform that integrates mechanical profiles with histopathology, genomics, imaging and patient metadata. The company states that its system and outputs are for investigational or research use only and are not cleared for diagnostic, prognostic or treatment decisions.

Customers are research labs in academia and industry, along with clinical research teams. Offerings listed on the website include selling the research device for installation in a lab or clinic, core lab services where customers send cells, hydrogels, organoids, preclinical tissues or fresh clinical biopsies, and a research collaboration network. The website does not disclose pricing or revenue figures.

The website states offices in Switzerland, the USA, Spain and Croatia; current job listings are in Basel, Zagreb and Houston. The legal entity named in the footer is ARTIDIS AG. Founders named on the site include CEO Dr. Marija Plodinec and Chief Medical Officer Dr. Marko Loparic. Open roles cover clinical operations, device operations, software engineering, data science and finance.

Product: ARTIDIS Research Device (automated, AI-assisted AFM platform), Artidisnet cloud analytics platform, and core lab sample-testing services.